Tnfrsf26 - tumor necrosis factor receptor superfamily, member 26

Predicted to enable identical protein binding activity and protease binding activity. Predicted to be involved in TRAIL-activated apoptotic signaling pathway and positive regulation of apoptotic process. Predicted to be located in Golgi apparatus; cytosol; and membrane raft. Predicted to be active in cell surface and plasma membrane. Is expressed in several structures, including heart; hemolymphoid system gland; liver; lung; and placenta. Human ortholog(s) of this gene implicated in carcinoma (multiple); cervical cancer; hematologic cancer (multiple); and urinary bladder cancer. Orthologous to human TNFRSF10A (TNF receptor superfamily member 10a) and TNFRSF10C (TNF receptor superfamily member 10c). [provided by Alliance of Genome Resources, Apr 2022]